[go: up one dir, main page]

PE20020513A1 - 2,4,8-TRISUSTITUIDE-8H-PYRID [2,3-d] PYRIMIDIN-7-ONA COMPOUNDS - Google Patents

2,4,8-TRISUSTITUIDE-8H-PYRID [2,3-d] PYRIMIDIN-7-ONA COMPOUNDS

Info

Publication number
PE20020513A1
PE20020513A1 PE2001001042A PE2001001042A PE20020513A1 PE 20020513 A1 PE20020513 A1 PE 20020513A1 PE 2001001042 A PE2001001042 A PE 2001001042A PE 2001001042 A PE2001001042 A PE 2001001042A PE 20020513 A1 PE20020513 A1 PE 20020513A1
Authority
PE
Peru
Prior art keywords
alkyl
pyrimidin
pyrid
ona
aryl
Prior art date
Application number
PE2001001042A
Other languages
Spanish (es)
Inventor
Jerry L Adams
Jeffrey C Boehm
Ralph Hall
Qi Jin
Jiri Kasparec
Domingos J Silva
John J Taggart
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of PE20020513A1 publication Critical patent/PE20020513A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE REFIERE A COMPUESTOS DE 2,4,8-TRISUSTITUIDA-8H-PIRIDO[2,3-d]PIRIMIDIN-7-ONA DE FORMULA I, Ia DONDE R1 ES ARILO, HETEROARILO; R2 ES H, ALQUILO C1-C10, CICLOALQUILO C3-C7, CICLOALQUIL C3-C7-ALQUILO, ARILO, ARIL-ALQUILO C1-C10, ENTRE OTROS; R3 ES ALQUILO C1-C10, CICLOALQUILO C3-C7, CICLOALQUILO C3-C7-ALQUILO C1-C4, ARILO, ARIL-ALQUILO C1-C10, ENTRE OTROS; X ES N(R10), O, S(O)m, CR10R20, ENTRE OTROS; R10 Y R20 ES H, ALQUILO C1-C4. SON COMPUESTOS PREFERIDOS 2-METILSULFANIL-4,8-DIFENIL-8H-PIRIDO[2,3-d]PIRIMIDIN-7-ONA, 2-(2-DIETILAMINO-ETILAMINO)-4,8-DIFENIL-8H-PIRIDO[2,3-d]PIRIMIDIN-7-ONA, 8-(2,6-DIFLUOROFENIL)-4-(4-FLUORO-2-METIL-FENIL)-2-METOXI-8H-PIRIDO[2,3-d]PIRIMIDIN-7-ONA, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. LOS COMPUESTOS MENCIONADOS SON INHIBIDORES DE LA CSBP/p38 QUINASA Y SON UTILES PARA EL TRATAMIENTO DE ARTRITIS, SINDROME DE REITER, GOTAREFERS TO 2,4,8-TRISUSTITUIDE-8H-PYRID [2,3-d] PYRIMIDIN-7-ONA COMPOUNDS OF FORMULA I, WHERE R1 IS ARYL, HETEROARYL; R2 IS H, C1-C10 ALKYL, C3-C7 CYCLOALKYL, C3-C7 CYCLOALKYL-ALKYL, ARYL, C1-C10 ARYL-ALKYL, AMONG OTHERS; R3 IS C1-C10 ALKYL, C3-C7 CYCLOALKYL, C3-C7 CYCLOALKYL-C1-C4 ALKYL, ARYL, ARYL-C1-C10 ALKYL, AMONG OTHERS; X IS N (R10), O, S (O) m, CR10R20, AMONG OTHERS; R10 AND R20 IS H, C1-C4 ALKYL. PREFERRED COMPOUNDS ARE 2-METHYLSULPHANIL-4,8-DIPHENYL-8H-PYRID [2,3-d] PYRIMIDIN-7-ONA, 2- (2-DIETHYLAMINE-ETHYLAMINE) -4,8-DIPHENYL-8H-PYRID [2 , 3-d] PYRIMIDIN-7-ONA, 8- (2,6-DIFLUOROPHENYL) -4- (4-FLUORO-2-METHYL-PHENYL) -2-METHOXY-8H-PYRIDO [2,3-d] PYRIMIDIN -7-ONA, AMONG OTHERS. IT ALSO REFERS TO A PHARMACEUTICAL COMPOSITION. THE MENTIONED COMPOUNDS ARE INHIBITORS OF CSBP / p38 KINASE AND ARE USEFUL FOR THE TREATMENT OF ARTHRITIS, REITER'S SYNDROME, Gout

PE2001001042A 2000-10-23 2001-10-19 2,4,8-TRISUSTITUIDE-8H-PYRID [2,3-d] PYRIMIDIN-7-ONA COMPOUNDS PE20020513A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24246100P 2000-10-23 2000-10-23
US31034901P 2001-08-06 2001-08-06

Publications (1)

Publication Number Publication Date
PE20020513A1 true PE20020513A1 (en) 2002-08-24

Family

ID=38812518

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001001042A PE20020513A1 (en) 2000-10-23 2001-10-19 2,4,8-TRISUSTITUIDE-8H-PYRID [2,3-d] PYRIMIDIN-7-ONA COMPOUNDS

Country Status (6)

Country Link
AR (1) AR035592A1 (en)
MY (1) MY145907A (en)
PE (1) PE20020513A1 (en)
SI (1) SI1333833T1 (en)
TW (2) TWI331149B (en)
UY (1) UY26980A1 (en)

Also Published As

Publication number Publication date
SI1333833T1 (en) 2011-12-30
TWI298722B (en) 2008-07-11
MY145907A (en) 2012-05-15
TW200815433A (en) 2008-04-01
UY26980A1 (en) 2002-06-20
TWI331149B (en) 2010-10-01
AR035592A1 (en) 2004-06-16

Similar Documents

Publication Publication Date Title
ATE302775T1 (en) CARBOLINE DERIVATIVES
GEP20074148B (en) Pyrrolo-triazine aniline compounds useful as kinase inhibitors
SE0202463D0 (en) Novel compounds
MXPA04004037A (en) Novel 1,2,4-triazole compound.
PA8501801A1 (en) TRIMYCLY POLYMERASE INHIBITORS (ADP - POLIRRIBOSAS)
PE20030702A1 (en) PDE9 INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS
MY125359A (en) Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods.
WO2003106428A8 (en) Arylsulphonamide derivatives and use thereof as b1 bradykinin receptor antagonists
PE20030471A1 (en) IMIDAZOPIRIDIN COMPOUND AS 5-HT4 RECEIVER MODULATORS
MXPA03010142A (en) Novel arylheteroalkylamine derivatives.
ATE346067T1 (en) CARBOLINE DERIVATIVES
MY152805A (en) Benzazepine derivatives useful as vasopressin antagonists
NO883487L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE HETEROCYCLIC COMPOUNDS.
MXPA05008584A (en) Heterocyclic compounds useful as nurr-1 activators.
SE9701304D0 (en) Compounds
SE9702564D0 (en) New compounds
IL163625A0 (en) Alkoxy-pyridine derivatives and pharmaceutical compositions containing the same
MXPA04009476A (en) (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors.
AP9901578A0 (en) Sulfonylbenzene compounds as anti-inflammatory/analgesic agents.
EA201070817A1 (en) IMIDAZO [1,2-α] PYRIDIN-2-CARBOXAMID DERIVATIVES, THEIR RECEIVING AND THEIR USE IN THERAPY
SE0302756D0 (en) Novel Compounds
TR200101711T2 (en) Antihistamine spiro compounds.
PE20100737A1 (en) NEW COMPOUNDS
MXPA02012470A (en) Cyclic gmp-specific phosphodiesterase inhibitors.
KR880013920A (en) Dihydropyridine Compound and Method for Preparing the Same

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed